Beyond The Pill 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 치료 영역별, 제공 형태별, 지역별 세분화 및 경쟁 구도(2020-2030년)
Beyond The Pill Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutic Area, By Offerings, By Region and Competition, 2020-2030F
상품코드:1879287
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 Beyond The Pill 시장은 2024년 2억 8,244만 달러에서 2030년까지 4억 1,644만 달러에 이르고, CAGR 6.69%를 보일 것으로 예측됩니다.
'세계 Beyond The Pill 시장'은 전통적인 의약품 개입을 넘어 환자 참여, 치료 순응도 및 전반적인 건강 결과를 개선하는 혁신적인 디지털 건강 솔루션, 서비스 및 스마트 기기를 포괄합니다. 이 시장의 성장을 뒷받침하는 주요 요인으로는 지속적인 관리가 필요한 만성질환의 전 세계적인 유병률 증가, 개인화된 헬스케어 개입의 필요성 증가, 원격 모니터링 및 인공지능과 같은 분야의 지속적인 기술 발전 등을 꼽을 수 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
2억 8,244만 달러
시장 규모 : 2030년
4억 1,644만 달러
CAGR : 2025-2030년
6.69%
성장 속도가 가장 빠른 부문
종양학
최대 시장
북미
주요 시장 성장 촉진요인
주요 시장 과제
주요 시장 동향
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 필 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
치료 영역별(당뇨병, 종양학, 심혈관 질환, 천식, 기타)
제공 내용별(서비스, 모니터링, 지원, 정보, 교육)
지역별
기업별(2024년)
시장 맵
제6장 북미의 필 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 필 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 필 시장 전망
시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 필 시장 전망
시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트(UAE)
남아프리카공화국
제10장 남미의 필 시장 전망
시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병(M&A)
제품 출시
최근 동향
제13장 세계의 필 시장을 넘어-치료 영역별, 제공 형태별, 지역별, 경쟁 구도 별 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 2020-2030년) : SWOT 분석
제14장 Porter의 Five Forces 분석
업계내 경쟁
신규 참여 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
F. Hoffmann-La Roche Ltd.(Flatiron Health, Inc.)
Otsuka Pharmaceutical Co., Ltd.
Amgen, Inc.
AstraZeneca PLC
Novartis AG
Sanofi S.A.
Novo Nordisk A/S
Eli Lilly and Company
Johnson & Johnson Services Inc.
Teva Pharmaceutical Industries Ltd.
제16장 전략적 제안
제17장 회사 소개 및 면책조항
LSH
영문 목차
영문목차
The Global Beyond The Pill Market will grow from USD 282.44 Million in 2024 to USD 416.44 Million by 2030 at a 6.69% CAGR. The "Global Beyond The Pill Market" encompasses innovative digital health solutions, services, and smart devices that extend beyond traditional pharmaceutical interventions to enhance patient engagement, treatment adherence, and overall health outcomes. Key drivers supporting this market's expansion include the increasing global prevalence of chronic diseases demanding continuous management, a growing imperative for personalized healthcare interventions, and continuous technological advancements in areas like remote monitoring and artificial intelligence.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 282.44 Million
Market Size 2030
USD 416.44 Million
CAGR 2025-2030
6.69%
Fastest Growing Segment
Oncology
Largest Market
North America
Key Market Drivers
The increasing global burden of chronic diseases represents a primary impetus for the expansion of the "Global Beyond The Pill Market." As populations age and lifestyles evolve, conditions such as diabetes, cardiovascular disease, and chronic respiratory illnesses necessitate continuous management beyond traditional episodic care. These long-term conditions demand solutions that support patient adherence, facilitate remote monitoring, and enable personalized interventions, thereby moving healthcare delivery beyond solely pharmaceutical products. According to the International Diabetes Federation's (IDF) Diabetes Atlas 2025, approximately 589 million adults are living with diabetes worldwide, underscoring the immense and growing patient pool requiring innovative, integrated care models. This persistent and escalating prevalence drives the need for digital health solutions that can effectively integrate into daily life, offering sustained support and improving long-term health outcomes.
Key Market Challenges
The complex and often fragmented global regulatory landscape represents a significant impediment to the growth of the "Global Beyond The Pill Market". This challenge manifests as increased costs and protracted timelines for product development and market access, directly hindering the widespread adoption of innovative digital health solutions. Manufacturers must navigate disparate national and regional requirements, leading to duplicative efforts in testing, documentation, and approval processes.
The financial burden imposed by these regulatory complexities is substantial. According to a MedTech Europe 2024 Regulatory Survey, medical device manufacturers anticipate a 50% increase in maintenance and re-certification costs over a five-year cycle due to evolving regulations. This escalation in operational expenses diminishes investment capacity for research and development into new digital health technologies, effectively slowing the pace of innovation.
Key Market Trends
Strategic Expansion into Solution Provider Models is fundamentally reshaping the "Global Beyond The Pill Market" by shifting the industry focus from standalone product sales to comprehensive, integrated digital health solutions. This trend involves medical technology companies developing ecosystems of devices, software, and supportive services to provide holistic patient management rather than episodic care. According to MedTech Europe's "Facts & Figures 2025" published in September 2025, digital health is rapidly scaling in Europe, driven by a convergence of breakthrough technologies, patient empowerment, and systemic efficiencies within the medical technology sector. This broader strategic emphasis enhances patient engagement and offers continuous support, transforming value creation in healthcare.
Key Market Players
F. Hoffmann-La Roche Ltd. (Flatiron Health, Inc.)
Otsuka Pharmaceutical Co., Ltd.
Amgen, Inc.
AstraZeneca PLC
Novartis AG
Sanofi S.A.
Novo Nordisk A/S
Eli Lilly and Company
Johnson & Johnson Services Inc.
Teva Pharmaceutical Industries Ltd.
Report Scope:
In this report, the Global Beyond The Pill Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Beyond The Pill Market , By Therapeutic Area:
Diabetes
Oncology
Cardiovascular Diseases
Asthma
Others
Beyond The Pill Market , By Offerings:
Services
Monitoring
Assistance
Information
Education
Beyond The Pill Market , By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Beyond The Pill Market .
Available Customizations:
Global Beyond The Pill Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Beyond The Pill Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Therapeutic Area (Diabetes, Oncology, Cardiovascular Diseases, Asthma, Others)
5.2.2. By Offerings (Services, Monitoring, Assistance, Information, Education)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Beyond The Pill Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapeutic Area
6.2.2. By Offerings
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Beyond The Pill Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Therapeutic Area
6.3.1.2.2. By Offerings
6.3.2. Canada Beyond The Pill Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Therapeutic Area
6.3.2.2.2. By Offerings
6.3.3. Mexico Beyond The Pill Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Therapeutic Area
6.3.3.2.2. By Offerings
7. Europe Beyond The Pill Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapeutic Area
7.2.2. By Offerings
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Beyond The Pill Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapeutic Area
7.3.1.2.2. By Offerings
7.3.2. France Beyond The Pill Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapeutic Area
7.3.2.2.2. By Offerings
7.3.3. United Kingdom Beyond The Pill Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapeutic Area
7.3.3.2.2. By Offerings
7.3.4. Italy Beyond The Pill Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Therapeutic Area
7.3.4.2.2. By Offerings
7.3.5. Spain Beyond The Pill Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Therapeutic Area
7.3.5.2.2. By Offerings
8. Asia Pacific Beyond The Pill Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapeutic Area
8.2.2. By Offerings
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Beyond The Pill Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapeutic Area
8.3.1.2.2. By Offerings
8.3.2. India Beyond The Pill Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapeutic Area
8.3.2.2.2. By Offerings
8.3.3. Japan Beyond The Pill Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapeutic Area
8.3.3.2.2. By Offerings
8.3.4. South Korea Beyond The Pill Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapeutic Area
8.3.4.2.2. By Offerings
8.3.5. Australia Beyond The Pill Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapeutic Area
8.3.5.2.2. By Offerings
9. Middle East & Africa Beyond The Pill Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapeutic Area
9.2.2. By Offerings
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Beyond The Pill Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapeutic Area
9.3.1.2.2. By Offerings
9.3.2. UAE Beyond The Pill Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapeutic Area
9.3.2.2.2. By Offerings
9.3.3. South Africa Beyond The Pill Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapeutic Area
9.3.3.2.2. By Offerings
10. South America Beyond The Pill Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapeutic Area
10.2.2. By Offerings
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Beyond The Pill Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapeutic Area
10.3.1.2.2. By Offerings
10.3.2. Colombia Beyond The Pill Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapeutic Area
10.3.2.2.2. By Offerings
10.3.3. Argentina Beyond The Pill Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapeutic Area
10.3.3.2.2. By Offerings
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Beyond The Pill Market : SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. F. Hoffmann-La Roche Ltd. (Flatiron Health, Inc.)
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Otsuka Pharmaceutical Co., Ltd.
15.3. Amgen, Inc.
15.4. AstraZeneca PLC
15.5. Novartis AG
15.6. Sanofi S.A.
15.7. Novo Nordisk A/S
15.8. Eli Lilly and Company
15.9. Johnson & Johnson Services Inc.
15.10. Teva Pharmaceutical Industries Ltd.
16. Strategic Recommendations
17. About Us & Disclaimer
(주)글로벌인포메이션02-2025-2992kr-info@giikorea.co.kr ⓒ Copyright Global Information, Inc. All rights reserved.
